Last week’s announcement by SCD that it will jointly develop and commercialize a weight-loss pill fueled a rally in the Korean company’s shares.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results